Jointly with matrix metalloproteinase-2 (MMP2), CCL5 regulates the migratory and invasive flow of glioma cells and consequently increases intracellular calcium levels as well as p-calcium/calmodulin-dependent protein kinase II (p-CaMKII) and p-AKT expressions [155]. The gene discussed is CCL5; the disease is central nervous system cancer.